Your browser doesn't support javascript.

BVS CLAP/SMR-OPAS/OMS

Centro Latino Americano de Perinatologia, Saúde da Mulher e Reprodutiva

Home > Pesquisa > ()
XML
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis / Eficacia de la vacuna contra el virus del papiloma humano en la prevención de verrugas anogenitales: revisión sistemática y metanálisis

Tejada, Romina A; Vargas, Kris G; Benites-Zapata, Vicente; Mezones-Holguín, Edward; Bolaños-Díaz, Rafael; Hernandez, Adrián V.
Salud pública Méx ; 59(1): 84-94, Jan.-Feb. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-846045
Abstract

Objective:

To review evidence on the efficacy of HPV vaccines in the prevention of non-cancer lesions (anogenital warts [AGW], recurrent laryngeal papillomatosis and oral papillomatosis). Materials and

methods:

We conducted a systematic review of randomized trials. We performed random effect models and effects were reported as relative risks (RR) and their confidence intervals (95%CI) following both intention to treat (ITT) and per protocol (PP) analyses.

Results:

We included six studies (n=27 078). One study was rated as high risk of bias. One study could not be included in the meta-analysis because it provided combined results. We found that quadrivalent vaccine reduced the risk of AGW by 62% (RR 0.38, 95%CI0.32-0.45, I20%) in the ITT analysis and by 95% (RR 0.05, 95%CI0.01-0.25, I266%) in the PP analysis. Subgroup analyses of studies in women or with low-risk of bias provided similar results.

Conclusion:

HPV quadrivalent vaccine is efficacious in preventing AGW in men and women.
Biblioteca responsável: BR1.1